Results 151 to 160 of about 7,752 (219)

Acute Encephalopathy in a Patient With Chronic Isotretinoin Exposure and Frequent Rizatriptan Use: A Case Report. [PDF]

Clin Case Rep
Roshanzamiri S, Rahimi M, Shadnia S, Erfantalab Evini P, Zandiyeh F, Mostafazadeh B.   +5 more
europepmc   +1 more source

Acute headache treatment in idiopathic intracranial hypertension: treating to the phenotype? [PDF]

J Headache Pain
Bsteh G, Krajnc N, Zaic S, Müller N, Marik W, Bertich M, Stapf C, Novak K, Macher S, Pemp B, Wöber C.   +10 more
europepmc   +1 more source

Correction to "Genetic Basis of the Negative Response to the Use of Triptans for the Treatment of Migraine-A Systematic Review and Meta-Analysis". [PDF]

Brain Behav
europepmc   +1 more source

Review of Analytical Methods for Identification and Determination of Triptans

Critical Reviews in Analytical Chemistry, 2009
A review of analytical methods for identification and determination of triptans which are a group of tryptamine based drugs used in the acute treatment of migraine headaches is presented.
Cafer Saka
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Triptans

Psychosomatics, 2002
Triptans are potent serotonin (5-HT) 1B/1D receptor agonists used to abort and treat migraine headaches. Although the triptans share pharmacodynamic characteristics at 5-HT(1B/1D) receptors, they differ pharmacokinetically. This column reviews how the triptans are metabolized. Generally, the triptans are metabolized by phase I monoamine oxidases (MAOs)
Scott C, Armstrong, Kelly L, Cozza
openaire   +2 more sources